financetom
Business
financetom
/
Business
/
Desjardins Comments on The Bank of Canada; 2nd of 2 Parts
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Desjardins Comments on The Bank of Canada; 2nd of 2 Parts
Aug 2, 2024 5:22 AM

07:47 AM EDT, 08/02/2024 (MT Newswires) -- since we're not ready to pencil in a recession just yet, the extent of the moves will be limited by the policy rate falling just 50bps below our neutral rate estimate (Chart). In a recession, the policy rate has tended to fall 250 to 300bps below neutral. Because we still see a path for the Bank of Canada to achieve a soft landing, we don't view such a dramatic decline in rates as necessary.

The extent to which the central bank cuts rates relative to the neutral rate estimate has important implications for the shape of the yield curve (Chart). The neutral rate provides an anchor for longer-term interest rates. So moving too far below means that curve steepening will be limited relative to past cutting cycles (Chart).

Also containing the steepening trend globally will be cash flowing from term deposits and money market funds into the longer end (Chart). Central bank rate cuts will work to make the yields on short-term debt instruments less attractive both in absolute terms and relative to securities with longer tenors. As cash migrates further out the yield curve, term premiums should remain contained.

All that being said, the magnitude of this easing cycle could be greater than we currently envisage if a domestic or global recession hits. Should a downturn take hold and begin to snowball, central bankers will need to cut rates more forcefully than what's accounted for in our base case forecast. That would lead to lower rates across the curve and also a steeper curve, as the policy rate falls further below neutral. For now, we believe central bankers are on the right track and can narrowly avoid a recession, meaning our base case forecast remains the most likely outcome with a recession just a downside risk.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Allakos Subcutaneous Therapy for Mast Cells-Related Diseases 'Well-Tolerated;' Shares Up After Hours
Allakos Subcutaneous Therapy for Mast Cells-Related Diseases 'Well-Tolerated;' Shares Up After Hours
Oct 10, 2024
04:55 PM EDT, 10/10/2024 (MT Newswires) -- Allakos ( ALLK ) said Thursday results of a phase 1 trial showed that a subcutaneously administered AK006, its investigational monoclonal antibody that selectively inhibits mast cells, was well-tolerated with a favorable safety profile. The company reported data from single dose subcutaneous AK006 up to 720 milligrams, with skin biopsies taken from treated...
CBL & Associates Properties Buys Back $12.5 Million Block of Shares
CBL & Associates Properties Buys Back $12.5 Million Block of Shares
Oct 10, 2024
04:53 PM EDT, 10/10/2024 (MT Newswires) -- CBL & Associates Properties ( CBL ) repurchased 500,000 shares for $12.5 million in a privately negotiated block trade with a single investor. The trade wasn't part of an existing repurchase program, CBL said Thursday in a statement. The company said it completed the share buyback program of up to $25 million on...
Heron Therapeutics Reaffirms Supply of Ready-to-Administer Nausea Prevention Medications
Heron Therapeutics Reaffirms Supply of Ready-to-Administer Nausea Prevention Medications
Oct 10, 2024
04:53 PM EDT, 10/10/2024 (MT Newswires) -- Heron Therapeutics ( HRTX ) said Thursday it can continue supplying its ready-to-administer chemotherapy-induced and postoperative nausea and vomit prevention medications Cinvanti, Sustol, and Aponvie amid the expected shortage of intravenous fluids caused by Hurricane Helene. The expected disruption in IV fluid supply is due to the temporary closure of a major manufacturing...
BRIEF-Millennium Management Reports 5.7%Passive Stake In Frontview REIT As Of Oct 4- SEC Filing
BRIEF-Millennium Management Reports 5.7%Passive Stake In Frontview REIT As Of Oct 4- SEC Filing
Oct 10, 2024
FrontView REIT Inc ( FVR ): * MILLENNIUM MANAGEMENT REPORTS 5.7%PASSIVE STAKE IN FRONTVIEW REIT AS OF OCT 4- SEC FILING Source text for Eikon: Further company coverage: ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved